Informative Patterns of Health-Care Utilization Prior to the Diagnosis of Pancreatic Ductal Adenocarcinoma

Gregory A. Coté, Huiping Xu, Jeffery J. Easler, Timothy D. Imler, Evgenia Teal, Stuart Sherman, Murray Korc

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Early-detection tests for pancreatic ductal adenocarcinoma (PDAC) are needed. Since a hypothetical screening test would be applied during antecedent clinical encounters, we sought to define the variability in health-care utilization leading up to PDAC diagnosis. This was a retrospective cohort study that included patients diagnosed with PDAC in the Indianapolis, Indiana, area between 1999 and 2013 with at least 1 health-care encounter during the antecedent 36-month period (n = 1,023). Patients were classified by unique patterns of health-care utilization using a group-based trajectory model. The prevalences of PDAC signals, such as diabetes mellitus (DM) and chronic pancreatitis, were compared. Four distinct trajectories were identified, the most common (42.0%) being having few clinical encounters more than 6 months prior to PDAC diagnosis (late acceleration). In all cases, a minority of persons had DM (30.6%, with 9.5% <1.5 years before PDAC) or any pancreatic disorder (39.9%); these were least common in the late-acceleration group (DM, 14.7%; any pancreatic disorder, 32.1% (P < 0.001)). The most common pattern of antecedent care was having few clinical encounters until shortly before PDAC diagnosis. Since the majority of patients diagnosed with PDAC do not have an antecedent PDAC signal, early-detection strategies limited to these groups may not apply to the majority of cases.

Original languageEnglish (US)
Pages (from-to)944-951
Number of pages8
JournalAmerican Journal of Epidemiology
Volume186
Issue number8
DOIs
StatePublished - Oct 15 2017

Fingerprint

Patient Acceptance of Health Care
Adenocarcinoma
Diabetes Mellitus
Delayed Diagnosis
Chronic Pancreatitis
Cohort Studies
Retrospective Studies
Delivery of Health Care

Keywords

  • Carcinoma
  • Chronic
  • Diabetes mellitus
  • Ductal
  • Pancreatic neoplasms
  • Pancreatitis

ASJC Scopus subject areas

  • Epidemiology

Cite this

Informative Patterns of Health-Care Utilization Prior to the Diagnosis of Pancreatic Ductal Adenocarcinoma. / Coté, Gregory A.; Xu, Huiping; Easler, Jeffery J.; Imler, Timothy D.; Teal, Evgenia; Sherman, Stuart; Korc, Murray.

In: American Journal of Epidemiology, Vol. 186, No. 8, 15.10.2017, p. 944-951.

Research output: Contribution to journalArticle

@article{b9e734180c0d4034a584b4c3eb7ac1a4,
title = "Informative Patterns of Health-Care Utilization Prior to the Diagnosis of Pancreatic Ductal Adenocarcinoma",
abstract = "Early-detection tests for pancreatic ductal adenocarcinoma (PDAC) are needed. Since a hypothetical screening test would be applied during antecedent clinical encounters, we sought to define the variability in health-care utilization leading up to PDAC diagnosis. This was a retrospective cohort study that included patients diagnosed with PDAC in the Indianapolis, Indiana, area between 1999 and 2013 with at least 1 health-care encounter during the antecedent 36-month period (n = 1,023). Patients were classified by unique patterns of health-care utilization using a group-based trajectory model. The prevalences of PDAC signals, such as diabetes mellitus (DM) and chronic pancreatitis, were compared. Four distinct trajectories were identified, the most common (42.0{\%}) being having few clinical encounters more than 6 months prior to PDAC diagnosis (late acceleration). In all cases, a minority of persons had DM (30.6{\%}, with 9.5{\%} <1.5 years before PDAC) or any pancreatic disorder (39.9{\%}); these were least common in the late-acceleration group (DM, 14.7{\%}; any pancreatic disorder, 32.1{\%} (P < 0.001)). The most common pattern of antecedent care was having few clinical encounters until shortly before PDAC diagnosis. Since the majority of patients diagnosed with PDAC do not have an antecedent PDAC signal, early-detection strategies limited to these groups may not apply to the majority of cases.",
keywords = "Carcinoma, Chronic, Diabetes mellitus, Ductal, Pancreatic neoplasms, Pancreatitis",
author = "Cot{\'e}, {Gregory A.} and Huiping Xu and Easler, {Jeffery J.} and Imler, {Timothy D.} and Evgenia Teal and Stuart Sherman and Murray Korc",
year = "2017",
month = "10",
day = "15",
doi = "10.1093/aje/kwx168",
language = "English (US)",
volume = "186",
pages = "944--951",
journal = "American Journal of Epidemiology",
issn = "0002-9262",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Informative Patterns of Health-Care Utilization Prior to the Diagnosis of Pancreatic Ductal Adenocarcinoma

AU - Coté, Gregory A.

AU - Xu, Huiping

AU - Easler, Jeffery J.

AU - Imler, Timothy D.

AU - Teal, Evgenia

AU - Sherman, Stuart

AU - Korc, Murray

PY - 2017/10/15

Y1 - 2017/10/15

N2 - Early-detection tests for pancreatic ductal adenocarcinoma (PDAC) are needed. Since a hypothetical screening test would be applied during antecedent clinical encounters, we sought to define the variability in health-care utilization leading up to PDAC diagnosis. This was a retrospective cohort study that included patients diagnosed with PDAC in the Indianapolis, Indiana, area between 1999 and 2013 with at least 1 health-care encounter during the antecedent 36-month period (n = 1,023). Patients were classified by unique patterns of health-care utilization using a group-based trajectory model. The prevalences of PDAC signals, such as diabetes mellitus (DM) and chronic pancreatitis, were compared. Four distinct trajectories were identified, the most common (42.0%) being having few clinical encounters more than 6 months prior to PDAC diagnosis (late acceleration). In all cases, a minority of persons had DM (30.6%, with 9.5% <1.5 years before PDAC) or any pancreatic disorder (39.9%); these were least common in the late-acceleration group (DM, 14.7%; any pancreatic disorder, 32.1% (P < 0.001)). The most common pattern of antecedent care was having few clinical encounters until shortly before PDAC diagnosis. Since the majority of patients diagnosed with PDAC do not have an antecedent PDAC signal, early-detection strategies limited to these groups may not apply to the majority of cases.

AB - Early-detection tests for pancreatic ductal adenocarcinoma (PDAC) are needed. Since a hypothetical screening test would be applied during antecedent clinical encounters, we sought to define the variability in health-care utilization leading up to PDAC diagnosis. This was a retrospective cohort study that included patients diagnosed with PDAC in the Indianapolis, Indiana, area between 1999 and 2013 with at least 1 health-care encounter during the antecedent 36-month period (n = 1,023). Patients were classified by unique patterns of health-care utilization using a group-based trajectory model. The prevalences of PDAC signals, such as diabetes mellitus (DM) and chronic pancreatitis, were compared. Four distinct trajectories were identified, the most common (42.0%) being having few clinical encounters more than 6 months prior to PDAC diagnosis (late acceleration). In all cases, a minority of persons had DM (30.6%, with 9.5% <1.5 years before PDAC) or any pancreatic disorder (39.9%); these were least common in the late-acceleration group (DM, 14.7%; any pancreatic disorder, 32.1% (P < 0.001)). The most common pattern of antecedent care was having few clinical encounters until shortly before PDAC diagnosis. Since the majority of patients diagnosed with PDAC do not have an antecedent PDAC signal, early-detection strategies limited to these groups may not apply to the majority of cases.

KW - Carcinoma

KW - Chronic

KW - Diabetes mellitus

KW - Ductal

KW - Pancreatic neoplasms

KW - Pancreatitis

UR - http://www.scopus.com/inward/record.url?scp=85031903543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031903543&partnerID=8YFLogxK

U2 - 10.1093/aje/kwx168

DO - 10.1093/aje/kwx168

M3 - Article

C2 - 28541521

AN - SCOPUS:85031903543

VL - 186

SP - 944

EP - 951

JO - American Journal of Epidemiology

JF - American Journal of Epidemiology

SN - 0002-9262

IS - 8

ER -